nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Rash generalised—Vemurafenib—skin cancer	0.058	0.058	CcSEcCtD
Levobunolol—Cerebral ischaemia—Temozolomide—skin cancer	0.0261	0.0261	CcSEcCtD
Levobunolol—Stinging—Imiquimod—skin cancer	0.026	0.026	CcSEcCtD
Levobunolol—Rash generalised—Docetaxel—skin cancer	0.0197	0.0197	CcSEcCtD
Levobunolol—Alopecia—Vismodegib—skin cancer	0.0177	0.0177	CcSEcCtD
Levobunolol—Nasal congestion—Imiquimod—skin cancer	0.0168	0.0168	CcSEcCtD
Levobunolol—Lethargy—Imiquimod—skin cancer	0.0156	0.0156	CcSEcCtD
Levobunolol—Cerebrovascular accident—Imiquimod—skin cancer	0.0156	0.0156	CcSEcCtD
Levobunolol—Stinging—Fluorouracil—skin cancer	0.0143	0.0143	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.0137	0.0137	CcSEcCtD
Levobunolol—Respiratory failure—Temozolomide—skin cancer	0.0128	0.0128	CcSEcCtD
Levobunolol—Pain—Vismodegib—skin cancer	0.0122	0.0122	CcSEcCtD
Levobunolol—Erectile dysfunction—Imiquimod—skin cancer	0.0122	0.0122	CcSEcCtD
Levobunolol—Depression—Imiquimod—skin cancer	0.0117	0.0117	CcSEcCtD
Levobunolol—Erythema multiforme—Vemurafenib—skin cancer	0.0117	0.0117	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.0117	0.0117	CcSEcCtD
Levobunolol—Conjunctivitis—Imiquimod—skin cancer	0.0114	0.0114	CcSEcCtD
Levobunolol—Cerebrovascular accident—Bleomycin—skin cancer	0.0111	0.0111	CcSEcCtD
Levobunolol—Alopecia—Vemurafenib—skin cancer	0.0109	0.0109	CcSEcCtD
Levobunolol—Lethargy—Dactinomycin—skin cancer	0.0103	0.0103	CcSEcCtD
Levobunolol—Asthenia—Vismodegib—skin cancer	0.0102	0.0102	CcSEcCtD
Levobunolol—Visual impairment—Imiquimod—skin cancer	0.0102	0.0102	CcSEcCtD
Levobunolol—Pruritus—Vismodegib—skin cancer	0.0101	0.0101	CcSEcCtD
Levobunolol—Nasal congestion—Temozolomide—skin cancer	0.01	0.01	CcSEcCtD
Levobunolol—Erythema multiforme—Imiquimod—skin cancer	0.00999	0.00999	CcSEcCtD
Levobunolol—Diarrhoea—Vismodegib—skin cancer	0.00975	0.00975	CcSEcCtD
Levobunolol—Arrhythmia—Imiquimod—skin cancer	0.00944	0.00944	CcSEcCtD
Levobunolol—Alopecia—Imiquimod—skin cancer	0.00934	0.00934	CcSEcCtD
Levobunolol—Bronchospasm—Bleomycin—skin cancer	0.00922	0.00922	CcSEcCtD
Levobunolol—Diplopia—Temozolomide—skin cancer	0.00915	0.00915	CcSEcCtD
Levobunolol—Ataxia—Temozolomide—skin cancer	0.00861	0.00861	CcSEcCtD
Levobunolol—Lethargy—Fluorouracil—skin cancer	0.00861	0.00861	CcSEcCtD
Levobunolol—Respiratory failure—Docetaxel—skin cancer	0.00854	0.00854	CcSEcCtD
Levobunolol—Nausea—Vismodegib—skin cancer	0.00846	0.00846	CcSEcCtD
Levobunolol—Syncope—Imiquimod—skin cancer	0.00825	0.00825	CcSEcCtD
Levobunolol—Hypotension—Vemurafenib—skin cancer	0.00823	0.00823	CcSEcCtD
Levobunolol—Palpitations—Imiquimod—skin cancer	0.00813	0.00813	CcSEcCtD
Levobunolol—Loss of consciousness—Imiquimod—skin cancer	0.00808	0.00808	CcSEcCtD
Levobunolol—Cardiac arrest—Fluorouracil—skin cancer	0.00802	0.00802	CcSEcCtD
Levobunolol—Ataxia—Fluorouracil—skin cancer	0.00793	0.00793	CcSEcCtD
Levobunolol—Chest pain—Imiquimod—skin cancer	0.00783	0.00783	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00773	0.00773	CcSEcCtD
Levobunolol—Shock—Imiquimod—skin cancer	0.00739	0.00739	CcSEcCtD
Levobunolol—Erectile dysfunction—Temozolomide—skin cancer	0.00729	0.00729	CcSEcCtD
Levobunolol—Depression—Temozolomide—skin cancer	0.00703	0.00703	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00699	0.00699	CcSEcCtD
Levobunolol—Paraesthesia—Imiquimod—skin cancer	0.00674	0.00674	CcSEcCtD
Levobunolol—Cardiac failure congestive—Docetaxel—skin cancer	0.00671	0.00671	CcSEcCtD
Levobunolol—Dyspnoea—Imiquimod—skin cancer	0.00669	0.00669	CcSEcCtD
Levobunolol—Alopecia—Bleomycin—skin cancer	0.00663	0.00663	CcSEcCtD
Levobunolol—Erythema multiforme—Dactinomycin—skin cancer	0.00662	0.00662	CcSEcCtD
Levobunolol—Hypersensitivity—Vemurafenib—skin cancer	0.00649	0.00649	CcSEcCtD
Levobunolol—Visual disturbance—Docetaxel—skin cancer	0.00642	0.00642	CcSEcCtD
Levobunolol—Pain—Imiquimod—skin cancer	0.00642	0.00642	CcSEcCtD
Levobunolol—Conjunctivitis—Fluorouracil—skin cancer	0.00632	0.00632	CcSEcCtD
Levobunolol—Asthenia—Vemurafenib—skin cancer	0.00632	0.00632	CcSEcCtD
Levobunolol—Pruritus—Vemurafenib—skin cancer	0.00623	0.00623	CcSEcCtD
Levobunolol—Lethargy—Docetaxel—skin cancer	0.00621	0.00621	CcSEcCtD
Levobunolol—Alopecia—Dactinomycin—skin cancer	0.00619	0.00619	CcSEcCtD
Levobunolol—Feeling abnormal—Imiquimod—skin cancer	0.00619	0.00619	CcSEcCtD
Levobunolol—Visual impairment—Temozolomide—skin cancer	0.0061	0.0061	CcSEcCtD
Levobunolol—Diarrhoea—Vemurafenib—skin cancer	0.00602	0.00602	CcSEcCtD
Levobunolol—Erythema multiforme—Temozolomide—skin cancer	0.00599	0.00599	CcSEcCtD
Levobunolol—Urticaria—Imiquimod—skin cancer	0.00596	0.00596	CcSEcCtD
Levobunolol—Dizziness—Vemurafenib—skin cancer	0.00582	0.00582	CcSEcCtD
Levobunolol—Ataxia—Docetaxel—skin cancer	0.00572	0.00572	CcSEcCtD
Levobunolol—Alopecia—Temozolomide—skin cancer	0.0056	0.0056	CcSEcCtD
Levobunolol—Chest pain—Bleomycin—skin cancer	0.00556	0.00556	CcSEcCtD
Levobunolol—Hypersensitivity—Imiquimod—skin cancer	0.00553	0.00553	CcSEcCtD
Levobunolol—Headache—Vemurafenib—skin cancer	0.00551	0.00551	CcSEcCtD
Levobunolol—Asthenia—Imiquimod—skin cancer	0.00539	0.00539	CcSEcCtD
Levobunolol—Confusional state—Bleomycin—skin cancer	0.00538	0.00538	CcSEcCtD
Levobunolol—Pruritus—Imiquimod—skin cancer	0.00531	0.00531	CcSEcCtD
Levobunolol—Nausea—Vemurafenib—skin cancer	0.00523	0.00523	CcSEcCtD
Levobunolol—Arrhythmia—Fluorouracil—skin cancer	0.00521	0.00521	CcSEcCtD
Levobunolol—Bronchospasm—Docetaxel—skin cancer	0.00517	0.00517	CcSEcCtD
Levobunolol—Alopecia—Fluorouracil—skin cancer	0.00516	0.00516	CcSEcCtD
Levobunolol—Diarrhoea—Imiquimod—skin cancer	0.00514	0.00514	CcSEcCtD
Levobunolol—Hypotension—Bleomycin—skin cancer	0.00498	0.00498	CcSEcCtD
Levobunolol—Dizziness—Imiquimod—skin cancer	0.00496	0.00496	CcSEcCtD
Levobunolol—Palpitations—Temozolomide—skin cancer	0.00487	0.00487	CcSEcCtD
Levobunolol—Paraesthesia—Bleomycin—skin cancer	0.00479	0.00479	CcSEcCtD
Levobunolol—Dyspnoea—Bleomycin—skin cancer	0.00475	0.00475	CcSEcCtD
Levobunolol—Headache—Imiquimod—skin cancer	0.0047	0.0047	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00465	0.00465	CcSEcCtD
Levobunolol—Pain—Bleomycin—skin cancer	0.00456	0.00456	CcSEcCtD
Levobunolol—Conjunctivitis—Docetaxel—skin cancer	0.00456	0.00456	CcSEcCtD
Levobunolol—Confusional state—Temozolomide—skin cancer	0.00454	0.00454	CcSEcCtD
Levobunolol—Nausea—Imiquimod—skin cancer	0.00446	0.00446	CcSEcCtD
Levobunolol—Feeling abnormal—Bleomycin—skin cancer	0.00439	0.00439	CcSEcCtD
Levobunolol—Chest pain—Fluorouracil—skin cancer	0.00432	0.00432	CcSEcCtD
Levobunolol—Pain—Dactinomycin—skin cancer	0.00425	0.00425	CcSEcCtD
Levobunolol—Urticaria—Bleomycin—skin cancer	0.00424	0.00424	CcSEcCtD
Levobunolol—Confusional state—Fluorouracil—skin cancer	0.00418	0.00418	CcSEcCtD
Levobunolol—Feeling abnormal—Dactinomycin—skin cancer	0.0041	0.0041	CcSEcCtD
Levobunolol—Visual impairment—Docetaxel—skin cancer	0.00406	0.00406	CcSEcCtD
Levobunolol—Paraesthesia—Temozolomide—skin cancer	0.00404	0.00404	CcSEcCtD
Levobunolol—Dyspnoea—Temozolomide—skin cancer	0.00401	0.00401	CcSEcCtD
Levobunolol—Erythema multiforme—Docetaxel—skin cancer	0.00398	0.00398	CcSEcCtD
Levobunolol—Hypersensitivity—Bleomycin—skin cancer	0.00393	0.00393	CcSEcCtD
Levobunolol—Hypotension—Fluorouracil—skin cancer	0.00387	0.00387	CcSEcCtD
Levobunolol—Pain—Temozolomide—skin cancer	0.00385	0.00385	CcSEcCtD
Levobunolol—Asthenia—Bleomycin—skin cancer	0.00383	0.00383	CcSEcCtD
Levobunolol—Pruritus—Bleomycin—skin cancer	0.00377	0.00377	CcSEcCtD
Levobunolol—Arrhythmia—Docetaxel—skin cancer	0.00376	0.00376	CcSEcCtD
Levobunolol—Paraesthesia—Fluorouracil—skin cancer	0.00372	0.00372	CcSEcCtD
Levobunolol—Alopecia—Docetaxel—skin cancer	0.00372	0.00372	CcSEcCtD
Levobunolol—Feeling abnormal—Temozolomide—skin cancer	0.00371	0.00371	CcSEcCtD
Levobunolol—Dyspnoea—Fluorouracil—skin cancer	0.0037	0.0037	CcSEcCtD
Levobunolol—Hypersensitivity—Dactinomycin—skin cancer	0.00366	0.00366	CcSEcCtD
Levobunolol—Urticaria—Temozolomide—skin cancer	0.00357	0.00357	CcSEcCtD
Levobunolol—Asthenia—Dactinomycin—skin cancer	0.00357	0.00357	CcSEcCtD
Levobunolol—Pain—Fluorouracil—skin cancer	0.00354	0.00354	CcSEcCtD
Levobunolol—Feeling abnormal—Fluorouracil—skin cancer	0.00342	0.00342	CcSEcCtD
Levobunolol—Diarrhoea—Dactinomycin—skin cancer	0.0034	0.0034	CcSEcCtD
Levobunolol—Hypersensitivity—Temozolomide—skin cancer	0.00331	0.00331	CcSEcCtD
Levobunolol—Urticaria—Fluorouracil—skin cancer	0.00329	0.00329	CcSEcCtD
Levobunolol—Syncope—Docetaxel—skin cancer	0.00329	0.00329	CcSEcCtD
Levobunolol—Palpitations—Docetaxel—skin cancer	0.00324	0.00324	CcSEcCtD
Levobunolol—Asthenia—Temozolomide—skin cancer	0.00323	0.00323	CcSEcCtD
Levobunolol—Loss of consciousness—Docetaxel—skin cancer	0.00322	0.00322	CcSEcCtD
Levobunolol—Pruritus—Temozolomide—skin cancer	0.00318	0.00318	CcSEcCtD
Levobunolol—Nausea—Bleomycin—skin cancer	0.00317	0.00317	CcSEcCtD
Levobunolol—Chest pain—Docetaxel—skin cancer	0.00312	0.00312	CcSEcCtD
Levobunolol—Diarrhoea—Temozolomide—skin cancer	0.00308	0.00308	CcSEcCtD
Levobunolol—Hypersensitivity—Fluorouracil—skin cancer	0.00305	0.00305	CcSEcCtD
Levobunolol—Confusional state—Docetaxel—skin cancer	0.00302	0.00302	CcSEcCtD
Levobunolol—Dizziness—Temozolomide—skin cancer	0.00297	0.00297	CcSEcCtD
Levobunolol—Nausea—Dactinomycin—skin cancer	0.00295	0.00295	CcSEcCtD
Levobunolol—Shock—Docetaxel—skin cancer	0.00294	0.00294	CcSEcCtD
Levobunolol—Pruritus—Fluorouracil—skin cancer	0.00293	0.00293	CcSEcCtD
Levobunolol—Diarrhoea—Fluorouracil—skin cancer	0.00284	0.00284	CcSEcCtD
Levobunolol—Headache—Temozolomide—skin cancer	0.00282	0.00282	CcSEcCtD
Levobunolol—Hypotension—Docetaxel—skin cancer	0.0028	0.0028	CcSEcCtD
Levobunolol—Dizziness—Fluorouracil—skin cancer	0.00274	0.00274	CcSEcCtD
Levobunolol—Paraesthesia—Docetaxel—skin cancer	0.00269	0.00269	CcSEcCtD
Levobunolol—Nausea—Temozolomide—skin cancer	0.00267	0.00267	CcSEcCtD
Levobunolol—Dyspnoea—Docetaxel—skin cancer	0.00267	0.00267	CcSEcCtD
Levobunolol—Headache—Fluorouracil—skin cancer	0.0026	0.0026	CcSEcCtD
Levobunolol—Pain—Docetaxel—skin cancer	0.00256	0.00256	CcSEcCtD
Levobunolol—Feeling abnormal—Docetaxel—skin cancer	0.00247	0.00247	CcSEcCtD
Levobunolol—Nausea—Fluorouracil—skin cancer	0.00246	0.00246	CcSEcCtD
Levobunolol—Hypersensitivity—Docetaxel—skin cancer	0.0022	0.0022	CcSEcCtD
Levobunolol—Asthenia—Docetaxel—skin cancer	0.00215	0.00215	CcSEcCtD
Levobunolol—Pruritus—Docetaxel—skin cancer	0.00212	0.00212	CcSEcCtD
Levobunolol—Diarrhoea—Docetaxel—skin cancer	0.00205	0.00205	CcSEcCtD
Levobunolol—Dizziness—Docetaxel—skin cancer	0.00198	0.00198	CcSEcCtD
Levobunolol—Headache—Docetaxel—skin cancer	0.00187	0.00187	CcSEcCtD
Levobunolol—Nausea—Docetaxel—skin cancer	0.00178	0.00178	CcSEcCtD
